Vela Diagnostics Sequencing System for Hiv1 Tender in USA - 147122049

Procurement Summary

Country: USA

Summary: Vela Diagnostics Sequencing System for Hiv1 Genotype Testing

Deadline: 27 Aug 2026

Posting Date: 13 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 147122049

Document Ref. No.: HT9426-26-NOI-5892

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Notice of Intent (NOI) to Sole Source
Title: Vela Sentosa SQ Next Generation Sequencing (NGS) for FDA Approved HIV-1 Genotype Sequencing
Requiring Activity: Walter Reed Army Institute of Research (WRAIR), Diagnostics and Countermeasures Branch (DCB)
Related Notice: HT9426-26-RFI-5892
Product Service Code (PSC): 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
North American Industry Classification System (NAICS) Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Small Business Size Standard: 1250 employees
The Defense Health Agency Contracting Activity (DHACA) on behalf of the Diagnostics and Countermeasures Branch (DCB) at the Walter Reed Army Institute of Research (WRAIR) intends to award a Firm Fixed Price contract on a sole source basis to Vela Diagnostics, USA INC; 353C US Highway 46; STE 250; Fairfield, New Jersey 07004; Cage Code 86YT5 under the RFO FAR 6.103-1 - Only one responsible source can supply the required products, and no other type of supplies or services will satisfy requirements.
Description of Services: Via a reagent rental agreement, the contractor shall provide all Sentosa sequencer kits, consumables, supplies, sequencing systems and sub-components, and maintenance and repair. The HIV Diagnostics and Reference Lab (HDRL), DCB at the WRAIR currently utilizes the Sentosa SQ Next Generation Sequencing (NGS) system in order to perform HIV genotype testing which is critical for the monitoring of drug resistance mutations in HIV-1 infected soldiers and their beneficiaries. The Sentosa NGS system includes instrumentation and reagents required to perform the Vela Sentosa SQ HIV-1 Genotype test in a College of American Pathologist (CAP) accredited laboratory. As the system and assay is Food and Drug Administration (FDA) approved, clinical testing laboratories are required to use the instruments and reagents approved by the FDA in the execution of the test. Market Research was conducted and indicated si...
Notice ID: ht9426-26-noi-5892

Department/Ind. Agency: dept of defense

Sub-tier: defense health agency (dha)

Office: army med res acq activity

Product Service Code: 6650 - optical instruments, test equipment, components and accessories

NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Inactive Dates: oct 31, 2026

Inactive Policy: manual

Disclaimer: The deadline date mentioned is tentative and provided for informational purposes only. This notice is a procurement forecast or general procurement plan, and not an active tender. Suppliers are advised to refer to the original documents and contact the issuing authority directly for the official tender release date and further details

Documents

 Tender Notice